Committee for Medicinal Products for Human Use

E139009

The Committee for Medicinal Products for Human Use is the European Medicines Agency’s expert body responsible for evaluating and providing scientific opinions on the safety, quality, and efficacy of medicines for human use in the European Union.

All labels observed (4)

How this entity was disambiguated

Statements (50)

Predicate Object
instanceOf expert body
regulatory body
scientific committee
abbreviation CHMP
appliesTo advanced therapy medicinal products
biosimilar medicines
centrally authorised medicines
generic medicines
innovative medicines
orphan medicines
composition co-opted members with specific expertise
members nominated by EEA-EFTA states
members nominated by EU Member States
country European Union
domain medicinal products for human use
field biostatistics
clinical pharmacology
drug safety
medicine regulation
pharmaceutical quality
pharmacology
public health
toxicology
formerlyKnownAs Committee for Proprietary Medicinal Products
hasRole adopt opinions on referrals for medicines
advise European Commission on medicinal products
assess efficacy of medicines
assess quality of medicines
assess safety of medicines
contribute to development of EU guidelines on medicinal products
coordinate EU-wide assessment of medicines
evaluate medicinal products for human use
issue opinions on benefit–risk balance of medicines
prepare opinions on extensions of marketing authorisations
prepare opinions on marketing authorisation applications
prepare opinions on renewals of marketing authorisations
prepare opinions on variations to marketing authorisations
provide scientific advice to medicine developers
provide scientific opinions on medicines
support pharmacovigilance activities
headquartersLocation Amsterdam
Netherlands
jurisdiction European Union
language English
parentOrganization European Medicines Agency
partOf European Medicines Agency
replaced Committee for Proprietary Medicinal Products
worksWith Committee for Advanced Therapies
Committee for Orphan Medicinal Products
Pharmacovigilance Risk Assessment Committee

How these facts were elicited

Referenced by (19)

Full triples — surface form annotated when it differs from this entity's canonical label.

European Medicines Agency hasCommittee Committee for Medicinal Products for Human Use
subject linked to: EMA
Regulation (EC) No 726/2004 establishes Committee for Medicinal Products for Human Use within the European Medicines Agency
linked to: Committee for Medicinal Products for Human Use
Committee for Proprietary Medicinal Products replacedBy Committee for Medicinal Products for Human Use
Committee for Proprietary Medicinal Products hasSuccessor Committee for Medicinal Products for Human Use
Committee for Proprietary Medicinal Products reorganizedInto Committee for Medicinal Products for Human Use
Paediatric Committee worksWith Committee for Medicinal Products for Human Use
Committee for Advanced Therapies worksWith Committee for Medicinal Products for Human Use
Pharmacovigilance Risk Assessment Committee collaboratesWith Committee for Medicinal Products for Human Use
Pharmacovigilance Risk Assessment Committee worksWith Committee for Medicinal Products for Human Use
CPMP partOf European Medicines Agency
linked to: Committee for Medicinal Products for Human Use
CPMP successor Committee for Medicinal Products for Human Use
CPMP successor CHMP
linked to: Committee for Medicinal Products for Human Use
CPMP replacedBy Committee for Medicinal Products for Human Use
CPMP replacedBy CHMP
linked to: Committee for Medicinal Products for Human Use
PDCO worksWith Committee for Medicinal Products for Human Use
Committee for Advanced Therapies worksWith Committee for Medicinal Products for Human Use
subject linked to: CAT
HMPC worksWith Committee for Medicinal Products for Human Use
Committee for Medicinal Products for Human Use abbreviation CHMP
linked to: Committee for Medicinal Products for Human Use